A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
ImmuneOncia Therapeutics Inc.
ImmuneOncia Therapeutics Inc.
Dren Bio
Bristol-Myers Squibb
Bristol-Myers Squibb
CStone Pharmaceuticals
Antengene Corporation
Sichuan Baili Pharmaceutical Co., Ltd.